Monoclonal Antibodies

From pre-clinical development to commercial supply, Patheon by Thermo Fisher Scientific is an industry leader in the development and manufacture of mammalian cell culture drug substances. Patheon offers biotech and pharmaceutical companies the ability to pursue opportunities around the globe with a fully i...

• Pegfilgrastim (Filed with EMA) • Filgrastim (Filed with EMA) • Trastuzumab (Filed with EMA, MHRA, Received recommendation for marketing authorization in India) • Bevacizumab (Filed with MHRA) • Omalizumab (Global PhIII ongoing) • Denosumab (Global PhIII ongoing) • Ranibizumab (Global PhIII ongoing...

This is our most advanced in-house project. A MabThera/Rituxan (rituximab) biosimilar drug, whose efficacy and safety were clinically confirmed. It is the first such advanced drug developed in Poland. We are currently at the final stage of works aimed at marketing the drug in Europe and the United States.

Nimotuzumab binds with intermediate affinity and high specificity to the extracellular domain of EGFR and blocks the binding of the EGF to its receptor and inhibits tumor cell growth. The molecule induces cell lysis through ADCC mechanism. Nimotuzumab provides vaccinal effect that induce memory T-cell ...

Bevacizumab acts by selectively binding circulating VEGF, thereby inhibiting the binding of VEGF to its cell surface receptors. This inhibition leads to a reduction in microvascular growth of tumor blood vessels that limits the blood supply to tumor tissues.The indication is for Colorectal Cancer...

A novel and proprietary hyaluronidase to enable subcutaneous administration of IV biologics. Currently partnered with 4 global pharmaceutical companies including two Top 10 global pharmaceutical companies. ALT-B4 has enhanced thermal stability and protein stability leading to longer shelf-life, has higher ...

Our Media are designed for small- and large-scale biomanufacturing and feature full and easy scalability.

Fermentation is mostly extracellular activity and is brought with the help of enzymes released by the microorganisms. The Fermenter is designed to meet all process requirement for micro-organism to achieve maximum growth and productivity. Features:
• Fully automated or semi-automated models
• 21...

For optimal clarification of biopharmaceutical manufacturing fluids, 3M’s extensive line of depth filters is versatile and adaptable for many processes. Our pharmaceutical-grade filters have high contaminant-holding capacity and provide economical filtration with reliable particle reduction.

Prolgolimab is the original fully human anti-PD1 monoclonal antibody for the treatment of advanced melanoma, advanced NSCLC and metastatic cervical cancer. Pending approval in Russia for melanoma in 2019. For marketing authorization in EU BIOCAD is starting Phase III clinical trials.